Showing results (571-580 of 634) with videos related to

Sort By:
Pageof 64
Cancer Research and Treatment|April 28, 2020
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal CancerJwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2009
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II studyJeeyun Lee, Kyung Hae Jung, Young Suk Park, et al.
The Lancet. Oncology|April 17, 2015
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 studyJosep Tabernero, Takayuki Yoshino, Allen Lee Cohn, et al.
The Lancet. Oncology|March 21, 2018
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trialRui-Hua Xu, Kei Muro, Satoshi Morita, et al.
Cells|April 27, 2026
<i>Adenophora divaricata</i> Franch. & Sav. Attenuates Particulate Matter-Induced Inflammatory Responses in RAW264.7 Macrophage CellsJi-Hye Ha, Ba-Wool Lee, Da-Hye Yi, et al.
The Lancet. Oncology|April 15, 2022
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 studyLuis A Diaz, Kai-Keen Shiu, Tae-Won Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2023
Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164Dung T Le, Luis A Diaz, Tae Won Kim, et al.
Cancer Research and Treatment|October 14, 2021
Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver MetastasesJesang Yu, Dong Hwan Kim, Jungbok Lee, et al.
Nature Medicine|February 20, 2024
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trialHyung-Don Kim, Seyoung Jung, Ho Yeong Lim, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 8, 2013
Iris Nertschinskia ethanol extract differentially induces cytotoxicity in human breast cancer cells depending on AKT1/2 activityJae-Sik Shin, Hyung-Gun Maeng, Seung-Woo Hong, et al.
Pageof 64